Christine Miller

LBY135, a novel anti‐DR5 agonistic antibody induces tumor cell–specific cytotoxic activity in human colon tumor cell lines and xenografts

Q. Deveraux, Youzhen Wang, C. Kowal, 2008 .

PTEN-deficient cancers depend on PIK3CB

Alice T. Loo, D. Wiederschain, F. Stegmeier, 2008, Proceedings of the National Academy of Sciences.

Antitumor efficacy of LBY135, an anti-DR5 monoclonal antibody, alone or in combination with chemotherapy in human colon tumor cell lines and xenografts

Q. Deveraux, Youzhen Wang, D. Stover, 2007 .

674 IL-27 signaling drives a type 1 interferon-like gene expression program of immunoregulatory pathways associated with cancer progression

D. Moodley, V. Palombella, J. Hua, 2021, Journal for ImmunoTherapy of Cancer.